Resources from the same session
Immune checkpoint inhibitor toxicities: What we know about mechanisms of action and current trends in management
Presenter: Joycelyn Lee
Session: Have we seen everything from checkpoints inhibitors?
Resources:
Slides
Webcast
New checkpoint inhibitors and combinations beyond PD1/PDL1
Presenter: Elena Garralda
Session: Have we seen everything from checkpoints inhibitors?
Resources:
Slides
Webcast
What do translational analytics teach us about IO therapy in solid tumours
Presenter: Kai-Keen Shiu
Session: Have we seen everything from checkpoints inhibitors?
Resources:
Slides
Webcast